PCRIX
Price
$13.95
Change
+$0.08 (+0.58%)
Updated
Jul 16 closing price
Net Assets
3.51B
PCRNX
Price
$13.83
Change
+$0.09 (+0.66%)
Updated
Jul 16 closing price
Net Assets
3.51B
Interact to see
Advertisement

PCRIX vs PCRNX

Header iconPCRIX vs PCRNX Comparison
Open Charts PCRIX vs PCRNXBanner chart's image
PIMCO Commodity Real Ret Strat Instl
Price$13.95
Change+$0.08 (+0.58%)
VolumeN/A
Net Assets3.51B
PIMCO Commodity Real Ret Strat I-3
Price$13.83
Change+$0.09 (+0.66%)
VolumeN/A
Net Assets3.51B
PCRIX vs PCRNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PCRIX vs. PCRNX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCRIX is a Hold and PCRNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PCRIX (3.51B) and PCRNX (3.51B) have equal amount of cash in the bank . PCRIX (4.62) and PCRNX (4.52) have matching dividends . PCRIX was incepted earlier than PCRNX: PCRIX (23 years) vs PCRNX (7 years). PCRNX (1.27) is less costly to investors than PCRIX (1.07). PCRIX (268.00) and PCRNX (268.00) have comparable annual turnover. PCRIX (1000000) and PCRNX (1000000) have matching initial minimum investment requirements. PCRIX (9.66) and PCRNX (9.44) have marching annual gain over last year. PCRIX (86.94) and PCRNX (85.56) have equivalent 5 years return.
PCRIXPCRNXPCRIX / PCRNX
Total Expense Ratio1.001.1587%
Annual Report Gross Expense Ratio1.071.2784%
Fund Existence23 years7 years-
Gain YTD8.9088.761102%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.51B3.51B100%
Annual Yield % from dividends4.624.52102%
Returns for 1 year9.669.44102%
Returns for 3 years3.212.72118%
Returns for 5 years86.9485.56102%
Returns for 10 years38.65N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FALIX58.34N/A
N/A
Fidelity Advisor Large Cap I
STVTX10.22N/A
N/A
Virtus Ceredex Large-Cap Value Equity I
TRGLX68.63N/A
N/A
T. Rowe Price Global Stock I
SCAUX11.50N/A
N/A
Invesco Income Advantage U.S. Fund A
SRIDX14.03N/A
N/A
Gabelli SRI I